{"cmr":"ca-cm-kg/TSX/APTX","since":null,"total":25,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-10-08","event_type":"financial_statement","title":"Apotex to Announce Second Quarter Fiscal 2027 Financial Results and Host Conference Call on November 12, 2026","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-to-announce-second-quarter-fiscal-2027-financial-results-and-host-conference-call-on-november-12-2026-899108243.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1n25mESzYCZ5KtHLOjcoRP8d2LmU53xE_iikvj4A82oRlmPUko1uAKlbVfxr002Jeuo7fS3VDvakH6I7AEAgBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-10-08","event_type":"newswire_release","title":"APOTEX - A Force For Health.","wire":"PR Newswire","source":"PR Newswire","url":"https://edge.prnewswire.com/c/link?t=0&l=en&o=4723139-1&h=4264476914&u=https%3A%2F%2Fwww.apotex.com%2Fglobal&a=www.apotex.com","read_by":"Tavily search (wire domains) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"blyQZd2cyamwvd_lZCfmfhs_YT9OFWRsnDOSIirJYs-01d7zogf-eSz7O_QbYGKjsl1uUge89vWvdiJRBIwxBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-10-05","event_type":"newswire_release","title":"APOTEX HEALTH CORP. ANNOUNCES CLOSING OF $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-health-corp-announces-closing-of-1-250-million-inaugural-senior-unsecured-notes-offering-859693393.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xBtzFVFAx9vYMiP4jpxe9FlYdgiS3TL9jZV-S-VrfwnTkwWZBiWp4Vqme8h88sERSshGb_3B79xg2k28KzsJCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-09-28","event_type":"newswire_release","title":"APOTEX HEALTH CORP. ANNOUNCES $1,250 MILLION INAUGURAL SENIOR UNSECURED NOTES OFFERING","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-health-corp-announces-1-250-million-inaugural-senior-unsecured-notes-offering-859215234.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"dsVFJhO3th6vfF0zt2TSbEth1k6XYuyRgL6BhVNTw7YbwdadJgK08qV0neT0yqnud27Vl5QFBBDubQVeV6QCDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-09-18","event_type":"newswire_release","title":"APOTEX HEALTH CORP. ANNOUNCES CLOSING OF UPSIZED BOUGHT DEAL SECONDARY OFFERING","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-health-corp-announces-closing-of-upsized-bought-deal-secondary-offering-870687397.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5VK-wErwPngMsOnCLE87mAa2XFha5LIU_ktivZ1z1ogG-kvhfR80_-V1YrHnSzcqtO5Y_n1nyqQaRZ1l3KWRDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-09-15","event_type":"newswire_release","title":"APOTEX HEALTH CORP. ANNOUNCES UPSIZE OF BOUGHT DEAL SECONDARY OFFERING TO $850 MILLION","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-health-corp-announces-upsize-of-bought-deal-secondary-offering-to-850-million-817038332.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nWIe0i-H3mp24JKTuoFVV-pBTUBzYNnvTf_ymasZIXUmCFkxhC3L7Vge5qRhtU4B9fw59BrcvqS1kIy90JXwBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-09-14","event_type":"newswire_release","title":"APOTEX HEALTH CORP. ANNOUNCES $750 MILLION BOUGHT DEAL SECONDARY OFFERING","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-health-corp-announces-750-million-bought-deal-secondary-offering-844452884.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"78ip7laDidpk18E1DNYa4U563ANwA6HWHEnTaN3MvtVg1sZ2VmX9Zmav5oypDtdDTajzPQyBDgTnq2vtxnZyCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-06-30","event_type":"newswire_release","title":"Apotex first to receive Health Canada approval for SEVMIA™, a generic semaglutide for chronic weight management","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/apotex-first-to-receive-health-canada-approval-for-sevmia-a-generic-semaglutide-for-chronic-weight-management-302815054.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"n1d3263Wj7iXC4ivCbYT0E7Fvc3IJag5nAB5mi6xycnPYSLhod2WAyAYGyRqkimzIQZleoMVLgtgBhz0HGvEBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-06-16","event_type":"newswire_release","title":"APOTEX HEALTH CORP. ANNOUNCES CLOSING OF UPSIZED INITIAL PUBLIC OFFERING AND EXERCISE OF OVER-ALLOTMENT OPTION IN FULL","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-health-corp-announces-closing-of-upsized-initial-public-offering-and-exercise-of-over-allotment-option-in-full-893548107.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"m2SpHl3W-WruUlS8WkSQJ1UahmnKQS7wGCBugUdSdXc1aEM276KgLbOWFXu8JK4_2xyxRy51-3nIp0QJWdkGBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-06-11","event_type":"newswire_release","title":"Apotex Health Corp. (APTX) Opens the Market","wire":"Newsfile","source":"Newsfile","url":"http://www.newsfilecorp.com/release/301076/Apotex-Health-Corp.-APTX-Opens-the-Market","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Mhvm7Fn9uysNCQtiqBL8Uwv1q_84Vwo43YsGKJDEklbuGbu6gOR2DIRqdzLYGq1tY_i70kaKRBlKAbIl4mL6CQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-06-11","event_type":"newswire_release","title":"Apotex Health Corp. (APTX) ouvre les marchés","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/301077/Apotex-Health-Corp.-APTX-ouvre-les-marchs","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RdPFwgdMJaQMUeG8D8KtYnFnxDtN8UEuDuo1q0Se-bP8iEsZJ_TQtF-Vhm6mEjUgTrb05_RvWa0F37jfoth8AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-06-10","event_type":"newswire_release","title":"APOTEX HEALTH CORP. FILES FINAL PROSPECTUS AND ANNOUNCES PRICING OF UPSIZED INITIAL PUBLIC OFFERING","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-health-corp-files-final-prospectus-and-announces-pricing-of-upsized-initial-public-offering-825567932.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"p5c4hmjDDW6-dllwZFmnufK3sad6nYUaI-2vRt0-f5qFbjfyhzhskx6IgeeJhWhjMFH-iZDu_A8o-c5g0jSoAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-06-09","event_type":"newswire_release","title":"APOTEX HEALTH CORP. UPSIZES ITS INITIAL PUBLIC OFFERING","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-health-corp-upsizes-its-initial-public-offering-832801597.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"EDdNncbX7SC9B4V8rzG5zs50ItNDMKjd4oC7HVkj9k1rbCbPDgAwTeUkqbt2iUT-zTPGGKKMzUaxTW1vl15nAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-05-28","event_type":"newswire_release","title":"APOTEX HEALTH CORP. FILES PRELIMINARY PROSPECTUS FOR INITIAL PUBLIC OFFERING","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-health-corp-files-preliminary-prospectus-for-initial-public-offering-889840420.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zTjN7X_jhSWMFp-FopBf9hFY-LJIql1DJqCFqIDppcfj-PqMeq2POEXQ46wB5svXpL8MwD2wip-w-SSIVcR7AQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-05-26","event_type":"newswire_release","title":"Apotex expands ophthalmic portfolio with Health Canada approval of IHEEZO™","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-expands-ophthalmic-portfolio-with-health-canada-approval-of-iheezo-tm--878450389.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"F-1EJ0V8NdL8LhexYnoRMZ3j1hZliWL9SdbDCsdFfe27XthSmkFmMPGi6bZtxlMbzJeAu_-2vnUlHv4V2Fp7Bw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-05-14","event_type":"newswire_release","title":"Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-launches-apo-semaglutide-injection-tm-a-generic-equivalent-of-ozempic-r-in-canada-831931261.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"92oF4ZnUw4Ba3RqnPipcLTVMsYLjna6-QmfC5GMgsCOMLEj-xn9Vbu_4YAk6HaKfilq40sWCoE60g06APAmfCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-05-01","event_type":"newswire_release","title":"Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-becomes-the-first-canadian-based-pharmaceutical-company-to-receive-health-canada-approval-for-a-generic-equivalent-of-ozempic-r--859489435.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"bb-lFgeI0DIX22kD4uT09UyAVMtBxke3z-jimgX8iclgS5IEGSb8GCQGvd3Ebgf11WSiIGuuxspzTjSB4ukjCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-05-01","event_type":"newswire_release","title":"Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/news-releases/apotex-becomes-the-first-canadianbased-pharmaceutical-company-to-receive-health-canada-approval-for-a-generic-equivalent-of-ozempic-302760415.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nReMgueN7z6N1NqVmTvqB9DenTk1sq1amizA99JfZ3tMfpCu2TtciEfqen4el9-PZWhkiY6pd7Ajx7e6_MBHCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-04-23","event_type":"newswire_release","title":"Apotex Announces Strategic Transaction with Cumberland Pharmaceuticals to Integrate their U.S. Branded Businesses","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-announces-strategic-transaction-with-cumberland-pharmaceuticals-to-integrate-their-u-s-branded-businesses-834749416.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qQ-tlIrkOvyp7utph6Qv60hsCHFl1IrkQ5Hkam98zyr-vqQop5TnPEuhrkn3HOPQ5jyfvZpmQFuF1ivfViaiBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-04-07","event_type":"newswire_release","title":"Apotex Strengthens Osteoporosis Care in Canada with Health Canada's Approval of DENOZA™, a Denosumab Biosimilar","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-strengthens-osteoporosis-care-in-canada-with-health-canada-s-approval-of-denoza-tm-a-denosumab-biosimilar-871237400.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"GdUpsCrJg_leJB1ZAAKlSvqkP5oq71W90NRTwuikMTXTbOzhltIVua02013baqQwTcOQqCH9OaNgbv1_7mG0Aw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-03-30","event_type":"newswire_release","title":"Apotex announces leadership changes","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-announces-leadership-changes-863711483.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nhI4P6nTU2EayPQox9ZgGu4oE9oVlEFzxu_Edb_tftLJhh7Z3Q0596ihT1TLzgM4ZGDloShjszxv6xl_3Vp7CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-03-25","event_type":"newswire_release","title":"Apotex Expands Canadian Ophthalmology Portfolio with Health Canada's Approval of CLOBIVIS™ (Clobetasol Propionate Ophthalmic Suspension, 0.05%)","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-expands-canadian-ophthalmology-portfolio-with-health-canada-s-approval-of-clobivis-tm-clobetasol-propionate-ophthalmic-suspension-0-05--836479618.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"H5q03PgvOGYwxrMQErYFUr_-qY7AjD5JbIQteFlDbwjgpERe3JnfNMdR4bVQAPY12-6wclwCGQhZd7clbkGQCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2026-02-05","event_type":"newswire_release","title":"Apotex licenses exclusive Canadian rights to testosterone replacement therapy Nebido® from Grünenthal","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-licenses-exclusive-canadian-rights-to-testosterone-replacement-therapy-nebido-r-from-grunenthal-866477053.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"hLHMIp5vg_SV6q7yyfgzghq4bRBu9_RvvwwwztJk-hRufxXKq64mXLMbzL_PvPueCnXU4CDVeJUvRN7zc5oeDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2025-10-23","event_type":"newswire_release","title":"Apotex Receives Health Canada Approval for LOQTORZI® -- The First and Only Immuno-Therapy for Recurrent Unresectable or Metastatic Nasopharyngeal Cancer","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-receives-health-canada-approval-for-loqtorzi-r-the-first-and-only-immuno-therapy-for-recurrent-unresectable-or-metastatic-nasopharyngeal-cancer-810051632.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NYktvTb749bVj0XkjUk2JTiJ0QToC4f0lIWWS3RyprIE09Kd_XMB9J0VGn-ziE-li5vHYAfd80WBw3j42vQ3Bw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/APTX","date":"2025-10-07","event_type":"newswire_release","title":"Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to \"Linzagolix\" for Uterine Fibroid Treatment","wire":"Canada Newswire (CNW)","source":"Canada Newswire (CNW)","url":"https://www.newswire.ca/news-releases/apotex-strengthens-commitment-to-women-s-health-with-exclusive-canadian-rights-to-linzagolix-for-uterine-fibroid-treatment-825267627.html","read_by":"newswire.ca company page","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1f0dR6x6dLMzwHjxy8HUovtmB9g3Wj5QU0TGClGZEYVDMksC-SVmXcdetoCiBhFt__E-BXn9vxrPA69U_lFcBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}